Differential up-regulation of erythropoietin and its receptor in benign and malignant prostatic tissue

Urol Oncol. 2010 May-Jun;28(3):314-9. doi: 10.1016/j.urolonc.2008.09.023. Epub 2008 Dec 12.

Abstract

Purpose: To investigate differential up-regulation of erythropoietin and its receptor in benign and malignant prostatic tissue.

Materials and methods: An immunohistochemical analysis of EPO and EPOR expression was performed on 30 cases of prostate carcinoma (PCa) with 16 high-grade prostate intraepithelial neoplasia (PIN), 50 cases of benign prostatic hyperplasia (BPH) lesions, and 30 normal prostatic tissue samples as control.

Results: Over-expression of EPOR was only shown in PCa and high-grade PIN tissue but over-expression of EPO was also shown in BPH tissue. There was significant relationship between EPO and EPOR score in BPH, high-grade PIN, and PCa but no association between EPOR or EPO score and Gleason score in PCa.

Conclusions: Up-regulation of EPOR has a more important role in comparison with EPO in prostate carcinogenesis. Differential over-expression of EPOR and EPO in benign and malignant prostatic tissue is ascribed to different mechanisms involved in up-regulation between EPO and EPOR.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Biomarkers, Tumor / analysis
  • Erythropoietin / biosynthesis*
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Prostatic Hyperplasia / metabolism*
  • Prostatic Hyperplasia / pathology
  • Prostatic Intraepithelial Neoplasia / metabolism*
  • Prostatic Intraepithelial Neoplasia / pathology
  • Prostatic Neoplasms / metabolism*
  • Prostatic Neoplasms / pathology
  • Receptors, Erythropoietin / biosynthesis*
  • Up-Regulation

Substances

  • Biomarkers, Tumor
  • Receptors, Erythropoietin
  • Erythropoietin